Key result
Postpartum preeclampsia linked to adverse maternal and neonatal outcomes.
Why the study?
While antepartum preeclampsia is well studied, considerably less is known about preeclampsia appearing after childbirth, and its maternal and infant consequences have not been fully established.
What are the maternal and infant consequences of postpartum preeclampsia?
What are the maternal and infant consequences of postpartum preeclampsia?
Supports postpartum BP screening to reduce associated morbidity; extends limited prior evidence in this understudied area.
( BJOG . 2025;132:752–759. doi: 10.1111/1471-0528.18030) Preeclampsia (PEC) is recognized as a major contributor to maternal and neonatal illness worldwide, typically manifesting during pregnancy through new-onset hypertension and related complications (proteinuria, end-organ and/or uteroplacental dysfunction) after 20 weeks of gestation. While antepartum PEC has been extensively studied, considerably less is known about cases that appear after childbirth. Although postpartum preeclampsia (PPPEC) is thought to originate from antenatal physiological changes, its consequences for mothers and infants have not been fully established. To address this gap, researchers conducted an extensive retrospective cohort study involving over 1.3 million hospital births in Quebec, Canada between 2006 and 2022.
No takes yet. Share an insight, caveat, or question.
Amar et al. (2026) studied this question. Postpartum preeclampsia, though less studied, significantly contributes to adverse maternal and neonatal outcomes, as shown in over 1.3 million Quebec births from 2006-2022.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: